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AT P-sensitive K + (K ATP ) channels were first identified in the sarcolemma of cardiac myocytes as inwardly rectifying K + channels that were inhibited by intracellular ATP (Noma, 1983) . It was proposed that K ATP channels would have a cardioprotective effect during ischemia by shortening action potential duration and thereby decreasing Ca 2+ influx into myocytes. Then it was found that K + channel opener compounds (KCOs) that are known to activate sarcolemmal K ATP channels exert cardioprotective effects under ischemia-reperfusion (Grover et al., 1989; Grover & Garlid, 2000) . However, several groups of investigators found that KCOs exerted cardioprotection at concentrations below those causing action potential shortening (Yao & Gross, 1994; Grover et al., 1995a; Grover et al., 1995b; Garlid et al., 1997) , indicating that KCOs may have targets other than sarcolemmal K ATP channels. Alternative targets for KCOs include mitochondrial K ATP (mitoK ATP ) channels (Grover & Garlid, 2000) .
The mitochondrial inner membrane is polarized by ~180 mV with the matrix side negative (m) due to a H + gradient generated by respiratory enzyme complexes ( Fig. 1) (Saraste, 1999 ). The energy stored in the form of m is utilized to make ATP from ADP by ATP synthetase. The inner mitochondrial membrane possesses different ion channels (uniports) through which cations such as K + , and Ca 2+ flow into the matrix under the normal electrochemical gradient and diminish m (Bernardi, 1999) . Inoue et al. (1991) were the first to identify K + -selective channels that were inhibited by ATP and glybenclamide in the inner membrane of liver mitochondria by using patch-clamp methods (Inoue et al., 1991) . Dahlem et al. also recently found similar channels in the inner mitochondrial membrane of Jurkat cells by using patch-clamp methods (Dahlem et al., 2004) . The existence of mitoK ATP channels in the heart was confirmed by different techniques such as reconstitution of mitochondrial membranes into bilayer lipid membranes and purified mitochondrial proteins into proteoliposomes (Grover & Garlid, 2000; Ardehali & O'Rourke, 2005) . In cardiac myocytes, diazoxide activated mitoK ATP 1,000-2,000 times more potently than sarcolemmal K ATP channels and it exerted cardioprotective effects during ischemia in this mitoK ATP -selective concentration range (Garlid et al., 1996; Garlid et al., 1997) . In addition, an inhibitor of mitoK ATP channels, 5-hydroxydecanoic acid (5-HD) abolished the cardioprotective effect of diazoxide. Taken together, these results suggested that it was mitoK AT P channels which play a pivotal role in cardioprotection evoked by KCOs. MitoK ATP channels were also proposed to be the end-effecter of ischemic preconditioning (Cohen et al., 2000) , a mechanism by which brief periods of ischemia provide protection against subsequent longer ischemic periods (Murry et al., 1986) . However, the mechanisms by which mitoK ATP channels exert their cardioprotective effects were poorly understood. An article from Terzic's laboratory published in the Journal Physiology in 1999 shed light on this issue (Holmuhamedov et al., 1999) . By using mitochondria isolated from rat hearts, the authors showed that diazoxide (>1 M) and another KCO, pinacidil (>10 M) lead to reduction of Ca 2+ influx through a ruthenium red-sensitive Ca 2+ uniport and an increase in Ca 2+ efflux through a cyclosporin A-sensitive mitochondrial permeability transition pore (PTP), a specific, voltage-dependent, nonselective high-conductance channel that is activated by an increase in the intra-mitochondrial Ca 2+ concentration ([Ca 2+ ] m ) and a decrease in m (Bernardi, 1999; Halestrap et al., 2004) . Holmuhamedov et al. further showed that these effects of KCOs were inhibited by ATP, abolished by removal of extra-mitochondrial KCl and mimicked by the K + ionophore valinomycin. They ascribed these effects to a decrease in m induced by the KCOs and thus a decrease in driving force for Ca 2+ influx, a hypothesis initially proposed by Liu et al. (1998) (Liu et al., 1998) . They also showed that diazoxide exerted a similar effect in a 5-HD-sensitive manner in intact cardiac myocytes. Murata et al. (2001) extended this work and showed that diazoxide reduced [Ca 2+ ] m in isolated cardiac myocytes under simulated ischemia/reperfusion in a 5-HD-sensitive manner (Murata et al., 2001) . Wang et al. (2001) reported that this was also the case in isolated hearts during ischemia/reperfusion and that the reduction in [Ca 2+ ] m by diazoxide correlated with the recovery of the contractility after reperfusion (Wang et al., 2001) .
However, Holmuhamedov's view was challenged by Kowaltowski et al. (2001) (Garlid, 2000; Kowaltowski et al., 2001) . They argued that the bioenergetic effects observed by Holmuhamedov et al. with high concentrations of KCOs (i.e. >100 M diazoxide or >50 M pinacidil) resulted not from activation of mitoK ATP channels but from drugs' protonophore activity and inhibitory effect on respiration. Furthermore, they found that the decrease in m induced in isolated mitochondria by diazoxide and pinacidil (<50 M) was too small (1-2 mV) to account for their cardioprotective effect. Instead, they found that the KCOs significantly increased the mitochondrial volume by causing a K + -influx and they suggested that this protected mitochondria during ischemia/reperfusion by preserving the architecture of the intermembrane space with consequent slowing of ATP hydrolysis and preservation of the ability to use creatine efficiently as substrate on reperfusion. On the other hand, Korge et al. (2002) found that although diazoxide hardly decreased m in energized mitochondria, it did so clearly in de-energized mitochondria (Korge et al., 2002) . They showed that diazoxide thereby decreased Ca 2+ influx and prevented Ca 2+ -induced opening of PTP, consistent with Holmuhamedov's view. Because widespread irreversible opening of PTP inevitably results in the necrosis of cardiac myocytes (Halestrap et al., 2004) , they ascribed cardioprotection by KCOs to this effect. They also found that diazoxide prevented the release of cytochrome c from the intermembrane space perhaps by causing mitochondrial swelling. This would prevent cardiac myocytes from undergoing apoptosis . It should be noted that KCO-induced opening of mitoK ATP channels may also cause cardioprotection by regulating the synthesis of reactive oxygen species during ischemia/reperfusion (Ardehali & O'Rourke, 2005) .
Thus, following Holmuhamedov's work (Holmuhamedov et al., 1999) , a number of investigators have proposed different mechanisms by which mitoK ATP channels can cause cardioprotection. Probably, these mechanisms are not mutually exclusive but coordinately cause cardioprotection during ischemia/perfusion (Ardehali & O'Rourke, 2005) . In spite of this remarkable progress, there still remain a number of questions regarding mitoK ATP channels. For instance, diazoxide and 5-HD are reputed to specifically target mitoK ATP channels but in fact both have other non-channel targets in mitochondria (Schafer et al., 1969；Hanley, 2002 Lim et al., 2002; Ozcan et al., 2002; Drose et al., 2006) Furthermore, it has been shown that diazoxide can activate sarcolemmal K ATP channels especially in the presence of intracellular ADP (D'Hahan et al., 1999) , and mouse atrial sarcolemmal K ATP channels are highly sensitive to diazoxide (Zhang et al., 2009) . Thus, one must be cautious in interpreting the effects of these agents. In addition, the molecular identity of mitoK ATP channels remains unclear (O'Rourke, 2000 (O'Rourke, , 2004 . The pharmacological similarities between mitoK ATP and sarcolemmal K ATP channels might suggest that mitoK ATP channels are composed of sulfonylurea receptors (SUR1, SUR2A or SUR2B) (receptors for KCOs and sulfonylureas) and pore-forming subunits (Kir6.1 or Kir6.2) as sarcolemmal K ATP channels (Seino, 1999) . Indeed, Grover and Garlid (2000) tentatively identified a 63 kDa sulfonylurea-binding protein and a putative pore-forming subunit of 55 kDa from mitochondria (Grover & Garlid, 2000) . Although some immunological analyses indicated the presence of these subunits in mitochondria (Suzuki et al., 1997; Lacza et al., 2003a; Lacza et al., 2003b; Singh et al., 2003; Cuong et al., 2005; Jiang et al., 2006) , these observations were not confirmed by other investigators (Seharaseyon et al., 2000; Kuniyasu et al., 2003; O'Rourke, 2004; Foster et al., 2008) . Liu et al. indicated that SUR1/Kir6.1 channels closely resembled mitoK ATP channels in their pharmacological properties (Liu et al., 2001) . However, diazoxide-induced protection of the brain from ischemia was observed equally in SUR1 knockout and wild-type mice in a 5-HD-sensitive manner, indicating that SUR1 is not a required component of mitoK ATP channels (Munoz et al., 2003) . Sehararaseyon et al. (2000) showed that transfection of a dominant negative construct of Kir6.1 did not affect mitoK ATP channel activity in isolated rabbit ventricular myocytes (Seharaseyon et al., 2000) , indicating that Kir6.1 is also not included in mitoK ATP channels. Recently, Ardehali et al. proposed an alternative hypothesis that mitoK ATP channels may be formed as a macromolecular complex containing mitochondrial ATP-binding cassette protein 1, phosphate carrier, adenine nucleotide translocator, ATP synthetase and succinate dehydrogenase (Ardehali et al., 2004) . Thus, mitoK ATP and sarcolemmal K ATP channels may be completely different molecules. Identification of the molecular structure of mitoK ATP channels will lead to more precise delineation of the mechanism underlying regulation of the channels and the development of drugs selectively acting on the channels. Therefore, further investigations are clearly needed in order to deepen our understanding of this important field of cardiovascular pathophysiology and pharmacology.
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Figure Legends
Figure 1: Ion transporters on the mitochondrial inner membrane described in the text. A horizontal gray bar indicates the mitochondrial inner membrane. This membrane is polarized by ~180 mV with matrix side negative (m) due to a H + gradient generated by respiratory enzyme complexes (REC) (Bernardi, 1999; Saraste, 1999) . The energy stored in the form of m is utilized to make ATP from ADP by ATP synthetase (AS). Mitochondrial ATP-sensitive channels (mitoK ATP ) mediate K + influx along m and cause a decrease in m, matrix swelling and regulation of reactive oxygen species (ROS) generation. MitoK ATP channels are activated by K + channel opener compounds (KCOs) and inhibited by ATP, glybenclamide (Glb) and 5-hydroxydecanoic acid (5-HD). A decrease in m inhibits Ca 2+ influx through Ca 2+ unipoters (Ca 2+ UP). Ca 2+ UP is inhibited by ruthenium red (RR). Mitochondrial permeability transition pore (PTP) is a specific, voltage-dependent, nonselective high-conductance channel that is activated by an increase in the intra-mitochondrial Ca 2+ concentration and a decrease in m. Ca 2+ efflux through PTP is also facilitated by a decrease in m. PTP is inhibited by cyclosporin A (Cys A). Figure 1 
